December 15, 2024

hormone

Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial

Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial

XPChronicle November 27, 2024
Two tables in this paper by Schaudig and colleagues (BMJ 2024;387:e079525, doi:10.1136/bmj-2024-079525, published 18 November 2024) required...
Read More

You may have missed

US officials in ‘direct contact’ with victorious Syria rebels US officials in 'direct contact' with victorious Syria rebels

US officials in ‘direct contact’ with victorious Syria rebels

December 15, 2024
ArdentComm CEO joins cultural efforts in Hong Kong ArdentComm CEO joins cultural efforts in Hong Kong

ArdentComm CEO joins cultural efforts in Hong Kong

December 15, 2024
Watch: How Killer Whales Hunt the Largest Fish in the Sea Orcas Bringing Whale to Surface

Watch: How Killer Whales Hunt the Largest Fish in the Sea

December 15, 2024
Bucks top Hawks, earn spot in NBA Cup title game Giannis Antetokounmpo Bucks NBA

Bucks top Hawks, earn spot in NBA Cup title game

December 15, 2024

Enjoy this blog? Please spread the word :)